COSMOS HEALTH INC (COSM)
US2214133058 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 56.24M 1.50% | 50.35M -10.47% | 53.377M 6.01% | 55.796M 4.53% | 69.743M 25.00% | |
| EBITDA YoY % growth | -4.19M -240.13% | -7.37M -75.89% | -21.217M -187.88% | -3.751M 82.32% | 2.438M 165.00% | |
| EBIT YoY % growth | -4.54M -266.91% | -7.47M -64.54% | -21.831M -192.25% | -8.79M 59.73% | 20.4K 100.23% | |
| Operating Margin | -8.07% | -14.84% | -40.90% | -15.75% | 0.03% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.80 -21.88% | 0.01 101.28% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 45.00% | -0.07 35.09% | -0.04 72.80% | 0.03 106.80% | 0.03 127.27% |
| Revenue Q2Q % growth | 14.79M -6.63% | 15.81M 8.41% | 17.825M 34.97% | 16.728M 34.78% | 19.38M 31.03% |
| EBITDA Q2Q % growth | -545.7K 95.79% | -459K 69.73% | 188.7K 110.10% | 1.433M 209.99% | 1.275M 333.64% |
| EBIT Q2Q % growth | -2.081M 84.68% | -1.071M 41.67% | -418.2K 83.29% | 831.3K 137.11% | 678.3K 132.60% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.45 | -0.11 | -0.34 | -301.07% |
| Q2 2024 Q2Q % growth | -0.15 | -0.14 | -0.01 | -5.04% |
| Q1 2024 Q2Q % growth | -0.11 | -0.14 | 0.03 | 22.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 12.411M -3.22% | 14.28M | -1.869M | -13.09% |
| Q2 2024 Q2Q % growth | 13.207M 6.85% | 15.555M | -2.348M | -15.09% |
| Q1 2024 Q2Q % growth | 14.584M 18.09% | 14.841M | -257K | -1.73% |
| Q4 2023 Q2Q % growth | 15.84M 31.45% | 14.025M | 1.815M | 12.94% |
| Q3 2023 Q2Q % growth | 12.824M 6.69% | % | ||
| Q2 2023 Q2Q % growth | 12.36M -6.43% | % | ||
| Q1 2023 Q2Q % growth | 12.35M -5.51% | % | ||
| Q4 2022 Q2Q % growth | 12.05M -25.53% | % | ||
| Q3 2022 Q2Q % growth | 12.02M -11.62% | % | ||
| Q2 2022 Q2Q % growth | 13.21M -11.04% | % | ||
| Q1 2022 Q2Q % growth | 13.07M 12.48% | % | ||
| Q4 2021 Q2Q % growth | 16.18M -0.74% | % | ||
| Q3 2021 Q2Q % growth | 13.6M -5.23% | % | ||
| Q2 2021 Q2Q % growth | 14.85M 15.83% | % | ||
| Q1 2021 Q2Q % growth | 11.62M -2.60% | % | ||
| Q4 2020 Q2Q % growth | 16.3M 38.25% | % | ||
| Q3 2020 Q2Q % growth | 14.35M 48.09% | % | ||
| Q2 2020 Q2Q % growth | 12.82M 50.65% | % | ||
| Q1 2020 Q2Q % growth | 11.93M 23.24% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -37.5% | -62.5% | -65.96% |
| Revenue | 0% | -17.38% | -2.82% | -2.82% |